The state of Arizona currently has 14 active clinical trials seeking participants for Multiple Sclerosis research studies. These trials are conducted in various cities, including Phoenix, Tucson, Scottsdale and Mesa.
Study to Evaluate the Efficacy, Safety and Tolerability of IMU-838 in Patients With Relapsing Multiple Sclerosis
Recruiting
Multi-Center, Randomized, Double-Blinded Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of IMU-838 versus Placebo in Adults with Relapsing Multiple Sclerosis (ENSURE-2)
Gender:
ALL
Ages:
Between 18 years and 55 years
Trial Updated:
04/17/2024
Locations: HonorHealth Research Institute - Bob Bove Neuroscience Institute, Scottsdale, Arizona
Conditions: Multiple Sclerosis, Relapsing-Remitting
ETNA-MS Device Validation Study
Recruiting
The overarching goal of this research protocol is to validate the effectiveness of Innodem's ETNA-MS device in informing clinicians on the disability status of Multiple Sclerosis (MS) patients. Effectiveness of the device will be assessed by the level of agreement between the EDSS estimated by the device and the actual scores measured by the neurologist in-person assessments.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
02/05/2024
Locations: MS Integrated Center, Phoenix, Arizona
Conditions: Multiple Sclerosis